06/20 - Ceros Capital Markets acted as exclusive placement agent for a significant portion in Dermasensor's Series A financing Read more »

In June 2019, Chris Dewey, Mark Goldwasser, and David Brown acquired Ceros Financial Services, Inc.

Since this acquisition, the Ceros Capital Markets division has focused on robotic surgery and minimally invasive, non-intrusive medical device companies and has successfully completed the following transactions:

TriFlo Cardio

3.7M

Valuation

TriFlo Cardiovascular is a biotechnology firm working in stealth mode.

Orthosensor

+$5M

Private

OrthoSensor is a medical device company developing devices and data services for the orthopedic sector.

InSightec

+$10M

Private

Develops and manufactures MR-guided focused ultrasound devices for image-guided acoustic surgery.

Dermasensor

+$7M

Private

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective...

Prior to joining Ceros, Chris Dewey had a long history of investing In companies with a valuation under $20 Million, many of which, at the time he invested, were valued under $10 Million. The value of the five companies is over $10 Billion.

ShockWave Medical

+$1.4B

Private

Developing the Lithoplasty™ family of balloon dilatation catheters that incorporate tiny lithotripsy electrodes shock.

Auris

+$5B

Private

Auris Health is a medical company that develops robotics technology for medical applications.

Procept

+$500M

Private

PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley

Mako

+ $1.65B

Private

MAKO Surgical is a medical device company specializing in robotic-arm assisted surgery in orthopedics.

Cephea

+$12M

Private

Cephea Valve Technologies, Inc. provides catheter delivered mitral valve regurgitation products/heart

* valuations provided are as of 7/1/2020

Browse our offerings

Ceros Capital Markets is bringing institutional quality
deals to family offices and qualified investors.

Get Started
blue skies ahead